CANNAPHARMARX INC (CPMD) Financial Statements (2026 and earlier)

Company Profile

Business Address 4439 TOWNSHIP RD 304
MOUNTAIN VIEW COUNTY, T0M 0R0
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments221228335
Cash and cash equivalent221228335
Receivables164  2321
Inventory, net of allowances, customer advances and progress billings1,1159961,134   
Inventory1,1159961,134   
Prepaid expense    69 132
Other current assets    6  
Other undisclosed current assets3020620  
Total current assets:1,3111,0191,19610030468
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization    5,128  
Operating lease, right-of-use asset5,5805,1615,870   
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization12713716210861,569
Other undisclosed noncurrent assets  4,5184,51879796,711
Total noncurrent assets:5,7079,81710,5505,314858,280
TOTAL ASSETS:7,01810,83611,7465,4141148,748
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:10,05911,7728,9717,2253,3242,544
Interest and dividends payable✕✕✕✕✕19496
Accounts payable 5,4704,7848,7816,8833,1292,448
Accrued liabilities4,3994,303524152  
Other undisclosed accounts payable and accrued liabilities1902,685(334)190  
Deferred revenue 261     
Debt483 3,3348,8578,9999,726
Derivative instruments and hedges, liabilities2,0091,1591,2641,0095073,677
Estimated litigation liability  190190   
Due to related parties✕✕✕✕ 20655
Other undisclosed current liabilities18,77812,6324,40474190947
Total current liabilities:31,59025,75218,16417,16513,04017,549
Noncurrent Liabilities
Liabilities, other than long-term debt5,034     
Operating lease, liability5,034     
Other undisclosed noncurrent liabilities5494,8935,7355,593  
Total noncurrent liabilities:5,5824,8935,7355,593  
Total liabilities:37,17230,64523,89922,75913,04017,549
Equity
Equity, attributable to parent, including:(30,154)(19,810)(12,153)(17,344)(12,926)(8,802)
Common stock66664427135
Treasury stock, value  (1) (0)(0)(0)
Common stock, value, subscriptions1     
Additional paid in capital81,52180,12375,82774,52473,05668,336
Accumulated other comprehensive income (loss)(57)556(36)240(372)(346)
Accumulated deficit(112,316)(101,184)(91,278)(94,695)(86,164)(77,332)
Other undisclosed equity, attributable to parent6316313,2902,559542535
Other undisclosed equity    (0)(0) 
Total equity:(30,154)(19,810)(12,153)(17,344)(12,926)(8,802)
TOTAL LIABILITIES AND EQUITY:7,01810,83611,7465,4141148,748

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues1,362820 402  
Other income    402  
Cost of revenue
(Cost of Product and Service Sold)
(3,447)(3,755)    
Gross profit:(2,085)(2,935) 402  
Operating expenses(1,263)(671)(1,581)(5,212)(2,993)(14,486)
Other undisclosed operating loss    (402)  
Operating loss:(3,348)(3,606)(1,581)(5,212)(2,993)(14,486)
Nonoperating income (expense)(7,784)(6,300)5,270(3,319)(5,839)(5,404)
Investment income, nonoperating   (79) (6,672) 
Debt instrument, convertible, beneficial conversion feature      1,358
Other nonoperating income (expense)(7,784)     
Interest and debt expense (837)(655)(930)(2,960)(2,294)
Other undisclosed income from continuing operations before equity method investments, income taxes      
Income (loss) from continuing operations before equity method investments, income taxes:(11,131)(10,742)3,034(9,461)(11,793)(22,184)
Other undisclosed income from continuing operations before income taxes    930 2,294
Income (loss) from continuing operations before income taxes:(11,131)(10,742)3,034(8,531)(11,793)(19,890)
Income tax expense (3,000)(1,704)    
Other undisclosed loss from continuing operations      
Income (loss) from continuing operations:(14,131)(12,447)3,034(8,531)(11,793)(19,890)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(11,793)(19,890)
Other undisclosed net income3,0002,541  2,960 
Net income (loss):(11,131)(9,906)3,034(8,531)(8,832)(19,890)
Other undisclosed net income attributable to parent  655   
Net income (loss) available to common stockholders, diluted:(11,131)(9,906)3,688(8,531)(8,832)(19,890)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(11,131)(9,906)3,034(8,531)(8,832)(19,890)
Other comprehensive loss (11,131)(9,906)    
Other undisclosed comprehensive loss      
Comprehensive income (loss):(22,263)(19,812)3,034(8,531)(8,832)(19,890)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent10,51910,497379612(26)(483)
Comprehensive income (loss), net of tax, attributable to parent:(11,744)(9,315)3,412(7,919)(8,859)(20,374)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: